Streptokinase and anti-thrombotic therapy in the hemolytic-uremic syndrome.
D001241:Aspirin / Q000627:therapeutic use; D001706:Biopsy; D002648:Child; D002675:Child, Preschool; D004176:Dipyridamole / Q000627:therapeutic use; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy* / Q000473:pathology; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007223:Infant; D007275:Injections, Intravenous; D007676:Kidney Failure, Chronic / Q000517:prevention & control; D007678:Kidney Glomerulus / Q000473:pathology; D010530:Peritoneal Dialysis; D012189:Retrospective Studies; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use*
D004176:Dipyridamole; D006493:Heparin; D013300:Streptokinase; D001241:Aspirin